Aortic Regurgitation, Time to Aortic Valve Reintervention, and Mortality in Degenerated Trifecta Versus Non-Trifecta Bioprosthesis
Amr E. Abbas(Oakland University), Alessandro Vivacqua(Beaumont Hospital, Royal Oak), Simon Dixon(Beaumont Hospital, Royal Oak), Brian Renard(Beaumont Hospital, Troy), Jeffrey Altshuler(Beaumont Hospital, Royal Oak), Elvis Cami(Beaumont Health), Ramy Mando(Beaumont Hospital, Troy), Bogdan A. Kindzelski(Beaumont Hospital, Royal Oak), Richard Bloomingdale(Oakland University), Ivan Hanson(Beaumont Hospital, Royal Oak), Luai Madanat(Corewell Health), Shailesh Niroula(Beaumont Hospital, Troy), Franco Fazzalari(Oakland University), Brittany Pridham(Beaumont Hospital, Troy), Rohit Chandra(Beaumont Hospital, Troy), Houman Khalili, Francis Shannon(Oakland University), Mazhed Kheyrbek(Beaumont Hospital, Troy)
Cited by 3
Related Papers
<i>TRAF1–C5</i> as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study
|New England Journal of Medicine|2007|830
3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis
|Journal of the American College of Cardiology|2023|176
Initial Findings From the North American COVID-19 Myocardial Infarction Registry
|Journal of the American College of Cardiology|2021|142
Impact of COVID‐19 pandemic on STEMI care: An expanded analysis from the United States
|Catheterization and Cardiovascular Interventions|2020|92
Incidence, Treatment, and Outcomes of Coronary Perforation During Chronic Total Occlusion Percutaneous Coronary Intervention
|The American Journal of Cardiology|2017|87